Texas Center for Cancer Nanomedicine
University of Texas Health Science Center
The Texas Center for Cancer Nanomedicine is developing and applying a diverse array of nanoplatforms for new therapeutics, methodologies for reliable monitoring of therapeutic efficacy, early detection approaches from biological fluids and advances in imaging, and cancer-prevention protocols for ovarian and pancreatic cancers.
David G. Gorenstein, Ph.D.
Mauro Ferrari, Ph.D.
Anil Sood, M.D.
Gabriel Lopez-Berestein, M.D.
View all Alliance News
- Project 1: Multistage Vectors for Ovarian Cancer Therapeutics
- Project 2: Nanotechnology Platforms for Targeting Ovarian Cancer Vasculature
- Project 3: Nanotechnology Platforms for the Prevention and Personalized Therapy of Pancreatic Adenocarcinoma
- Project 4: Multifunctional Nanoassemblies for Ligand-Directed Imaging and Therapy of Endocrine Pancreatic Tumors